BEDROSIAN CAMILLE L (Chief Medical Officer) received a stock award from AMYLYX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/21/2026ACC: 0001193125-26-359676
Officer· Chief Medical Officer
Since Mar 2026
+22.81K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
22.81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.81K
Price / share
—
Trade value
—
% of position
8.6%
8/18/2026
265.29K→288.09K
Total
Net shares
+22.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | A · Award | +22.81K | — | — | 8.6% | 265.29K | 288.09K |
| Total | +22.81K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported